Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MELPHALAN Cause Neoplasm progression? 97 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 97 reports of Neoplasm progression have been filed in association with MELPHALAN (Melphalan Hydrochloride). This represents 0.6% of all adverse event reports for MELPHALAN.

97
Reports of Neoplasm progression with MELPHALAN
0.6%
of all MELPHALAN reports
53
Deaths
39
Hospitalizations

How Dangerous Is Neoplasm progression From MELPHALAN?

Of the 97 reports, 53 (54.6%) resulted in death, 39 (40.2%) required hospitalization, and 4 (4.1%) were considered life-threatening.

Is Neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MELPHALAN. However, 97 reports have been filed with the FAERS database.

What Other Side Effects Does MELPHALAN Cause?

Off label use (2,002) Febrile neutropenia (931) Drug ineffective (853) Neutropenia (810) Mucosal inflammation (804) Plasma cell myeloma (781) Product use in unapproved indication (765) Thrombocytopenia (701) Diarrhoea (698) Pyrexia (667)

What Other Drugs Cause Neoplasm progression?

PALBOCICLIB (10,885) SUNITINIB MALATE (1,920) CYCLOPHOSPHAMIDE (1,588) CARBOPLATIN (1,370) AXITINIB (1,315) DOXORUBICIN (1,276) LETROZOLE (1,225) PACLITAXEL (1,180) CRIZOTINIB (1,161) VINCRISTINE (1,106)

Which MELPHALAN Alternatives Have Lower Neoplasm progression Risk?

MELPHALAN vs MEMANTINE MELPHALAN vs MENINGOCOCCAL GROUP B VACCINE MELPHALAN vs MENINGOCOCCAL POLYSACCHARIDE VACCINE A\NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN MELPHALAN vs MENOTROPINS MELPHALAN vs MENTHOL

Related Pages

MELPHALAN Full Profile All Neoplasm progression Reports All Drugs Causing Neoplasm progression MELPHALAN Demographics